Evelo Biosciences, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$81.8M

255 transactions

Summary

Evelo Biosciences, Inc. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $81.6MSales: $143K46 insiders

Date	Insider	Type	Value
2023-11-02	McHale Duncan(Chief Medical Officer)	Sell	$2K
2023-11-02	Bodmer Mark(CSO, President of R&D)	Sell	$2K
2023-11-02	Thorell Marella(Chief Financial Officer)	Sell	$1K
2023-11-08	Bodmer Mark(CSO, President of R&D)	Sell	$1K
2023-11-08	McHale Duncan(Chief Medical Officer)	Sell	$1K
2023-11-08	Thorell Marella(Chief Financial Officer)	Sell	$597.63
2023-11-08	GILL SIMBA(President & CEO)	Sell	$56.76
2023-11-07	Thorell Marella(Chief Financial Officer)	M	$0
2023-11-07	Thorell Marella(Chief Financial Officer)	M	—
2023-11-07	GILL SIMBA(President & CEO)	M	$0
2023-11-07	GILL SIMBA(President & CEO)	M	—
2023-11-07	McHale Duncan(Chief Medical Officer)	M	$0
2023-11-07	McHale Duncan(Chief Medical Officer)	M	—
2023-11-07	Bodmer Mark(CSO, President of R&D)	M	$0
2023-11-07	Bodmer Mark(CSO, President of R&D)	M	—
2023-11-01	Thorell Marella(Chief Financial Officer)	M	$0
2023-11-01	Thorell Marella(Chief Financial Officer)	M	—
2023-11-01	McHale Duncan(Chief Medical Officer)	M	$0
2023-11-01	McHale Duncan(Chief Medical Officer)	M	—
2023-11-01	Bodmer Mark(CSO, President of R&D)	M	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Evelo Biosciences, Inc. — Contributions, Lobbying & Contracts | Poliscope